PDCD1 and nasopharyngeal carcinoma: Therefore, considering the tremendous therapeutic potential of targeting the PD-1/PD-L1 interaction in NPC, we analysed the prognostic value of PD-1 and PD-L1 in a cohort of NPC patients (n = 99), which were consecutively recruited form a single medical care group over the course of two years.